1. Home
  2. SLNO vs PI Comparison

SLNO vs PI Comparison

Compare SLNO & PI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • PI
  • Stock Information
  • Founded
  • SLNO 1999
  • PI 2000
  • Country
  • SLNO United States
  • PI United States
  • Employees
  • SLNO N/A
  • PI N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PI Industrial Machinery/Components
  • Sector
  • SLNO Health Care
  • PI Technology
  • Exchange
  • SLNO Nasdaq
  • PI Nasdaq
  • Market Cap
  • SLNO 3.8B
  • PI 3.2B
  • IPO Year
  • SLNO 2014
  • PI 2016
  • Fundamental
  • Price
  • SLNO $68.57
  • PI $176.82
  • Analyst Decision
  • SLNO Strong Buy
  • PI Buy
  • Analyst Count
  • SLNO 10
  • PI 6
  • Target Price
  • SLNO $112.50
  • PI $148.67
  • AVG Volume (30 Days)
  • SLNO 1.6M
  • PI 604.6K
  • Earning Date
  • SLNO 08-06-2025
  • PI 07-30-2025
  • Dividend Yield
  • SLNO N/A
  • PI N/A
  • EPS Growth
  • SLNO N/A
  • PI N/A
  • EPS
  • SLNO N/A
  • PI N/A
  • Revenue
  • SLNO $32,656,999.00
  • PI $358,938,000.00
  • Revenue This Year
  • SLNO N/A
  • PI N/A
  • Revenue Next Year
  • SLNO $209.31
  • PI $25.13
  • P/E Ratio
  • SLNO N/A
  • PI N/A
  • Revenue Growth
  • SLNO N/A
  • PI 13.96
  • 52 Week Low
  • SLNO $41.50
  • PI $60.85
  • 52 Week High
  • SLNO $90.32
  • PI $239.88
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 32.58
  • PI 73.33
  • Support Level
  • SLNO $66.72
  • PI $160.06
  • Resistance Level
  • SLNO $87.17
  • PI $168.89
  • Average True Range (ATR)
  • SLNO 3.81
  • PI 7.37
  • MACD
  • SLNO -1.52
  • PI 0.20
  • Stochastic Oscillator
  • SLNO 21.55
  • PI 81.37

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

Share on Social Networks: